786
Views
24
CrossRef citations to date
0
Altmetric
Review

Pharmacotherapy for onychomycosis: new and emerging treatments

Pages 725-735 | Received 09 Nov 2018, Accepted 14 Jan 2019, Published online: 28 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Aditya K. Gupta, Shruthi Polla Ravi, Sandor Haas-Neill, Tong Wang & Elizabeth A. Cooper. (2023) Utility of devices for onychomycosis: a review. Journal of Dermatological Treatment 34:1.
Read now
Julianne M Falotico & Shari R Lipner. (2022) Updated Perspectives on the Diagnosis and Management of Onychomycosis. Clinical, Cosmetic and Investigational Dermatology 15, pages 1933-1957.
Read now
Jose W. Ricardo & Shari R. Lipner. (2020) Safety of current therapies for onychomycosis. Expert Opinion on Drug Safety 19:11, pages 1395-1408.
Read now

Articles from other publishers (20)

Katie Roster, Yu Wang & Shari R. Lipner. (2023) Retrospective analysis of onychomycosis prescribing patterns using the medicare part D prescribers database 2016–2020. Mycoses 67:1.
Crossref
Sebastian Gnat, Dominik Łagowski, Mariusz Dyląg, Grzegorz Jóźwiak, Aleksandra Trościańczyk & Aneta Nowakiewicz. (2022) In Vitro Activity of Ebselen and Diphenyl Diselenide Alone and in Combination with Drugs against Trichophyton mentagrophytes Strains. Pharmaceutics 14:6, pages 1158.
Crossref
Yu Wang & Shari R. Lipner. (2022) Analysis of utilization, cost and, prescription trends of onychomycosis medications among Medicare patients. Journal of the American Academy of Dermatology 86:2, pages 440-442.
Crossref
Praveen Kolimi, Vijay Kumar Shankar, Abhishek Shettar, Srinath Rangappa, Michael A. Repka & S. Narasimha Murthy. (2022) Development and Validation of HPLC Method for Efinaconazole: Application to Human Nail Permeation Studies. AAPS PharmSciTech 23:1.
Crossref
Ulrike Blume‐Peytavi, Antonella Tosti, Meritxell Falqués, Maria Luisa Tamarit, Cristina Carreño, Jordi Galván & Veronica Tebbs. (2021) A multicentre, randomised, parallel‐group, double‐blind, vehicle‐controlled and open‐label, active‐controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis. Mycoses.
Crossref
Sebastian Gnat, Dominik Łagowski, Mariusz Dyląg, Jessica Zielinski, Marek Studziński & Aneta Nowakiewicz. (2021) Cold atmospheric pressure plasma (CAPP) as a new alternative treatment method for onychomycosis caused by Trichophyton verrucosum: in vitro studies. Infection 49:6, pages 1233-1240.
Crossref
Claire R. Stewart, Leah Algu, Rakhshan Kamran, Cameron F. Leveille, Khizar Abid, Charlene Rae & Shari R. Lipner. (2021) Effect of onychomycosis and treatment on patient-reported quality-of-life outcomes: A systematic review. Journal of the American Academy of Dermatology 85:5, pages 1227-1239.
Crossref
Danuta Nowicka & Urszula Nawrot. (2021) Tinea pedis—An embarrassing problem for health and beauty—A narrative review. Mycoses 64:10, pages 1140-1150.
Crossref
Bárbara Costa, Bruna Pippi, Simone Jacobus Berlitz, Anderson Ramos Carvalho, Mario Lettieri Teixeira, Irene Clemes Külkamp‐Guerreiro, Saulo F. Andrade & Alexandre Meneghello Fuentefria. (2021) Evaluation of activity and toxicity of combining clioquinol with ciclopirox and terbinafine in alternative models of dermatophytosis. Mycoses 64:7, pages 727-733.
Crossref
Ghada Bouz & Jan Zitko. (2021) Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review. Bioorganic Chemistry 110, pages 104806.
Crossref
Derry K Mercer, Jennifer C Robertson, Lorna Miller, Colin S Stewart & Deborah A O'Neil. (2020) NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile. Medical Mycology 58:8, pages 1064-1072.
Crossref
Diba Abdollahi, Zahra Jafariazar & Minoo Afshar. (2020) Effect of monoterpenes on ex vivo transungual delivery of itraconazole for the management of onychomycosis. Journal of Cosmetic Dermatology 19:10, pages 2745-2751.
Crossref
Linghong Linda Zhou, Sabrina Nurmohamed, Sheila Au, Jennifer Beecker, Peter Green, Lynne Robertson & Regine Mydlarski. (2020) The Canadian Dermatology Association’s Top Five Choosing Wisely Canada Recommendations. Journal of Cutaneous Medicine and Surgery 24:5, pages 461-467.
Crossref
Krysta Lin & Shari R. Lipner. (2020) Modeling of usage and estimation of cost for efinaconazole 10% topical solution in the treatment of onychomycosis. Journal of the American Academy of Dermatology 83:1, pages 227-228.
Crossref
Mohammed Abu El‐Hamd, Manar Ibrahim Abd Elhameed, Mona Fattouh Mohamed Shalaby & Ramadan Saleh. (2020) In vitro antifungal susceptibility testing of fungi in patients with onychomycosis. Dermatologic Therapy 33:3.
Crossref
Alexander K.C. Leung, Joseph M. Lam, Kin F. Leong, Kam L. Hon, Benjamin Barankin, Amy A.M. Leung & Alex H.C. Wong. (2020) Onychomycosis: An Updated Review. Recent Patents on Inflammation & Allergy Drug Discovery 14:1, pages 32-45.
Crossref
Silvia Tampucci, Eleonora Terreni, Erica Zucchetti, Susi Burgalassi, Patrizia Chetoni & Daniela Monti. (2020) Formulations Based on Natural Ingredients for the Treatment of Nail Diseases. Current Pharmaceutical Design 26:5, pages 556-565.
Crossref
Nami Hasegawa & Kazutoshi Shibuya. (2020) Development of an Animal Model of Onychomycosis in Guinea Pigs. Medical Mycology Journal 61:4, pages 55-60.
Crossref
Aline Chiodi Borges, Thalita Mayumi Castaldelli Nishime, Sabrina de Moura Rovetta, Gabriela de Morais Gouvêa Lima, Konstantin Georgiev Kostov, Gilmar Patrocínio Thim, Beatriz Rossi Canuto de Menezes, João Paulo Barros Machado & Cristiane Yumi Koga-Ito. (2019) Cold Atmospheric Pressure Plasma Jet Reduces Trichophyton rubrum Adherence and Infection Capacity. Mycopathologia 184:5, pages 585-595.
Crossref
Tara L. Beuscher & Teresa J. Kelechi. (2019) Onychomycosis. Journal of Wound, Ostomy and Continence Nursing 46:4, pages 333-335.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.